Quantum Biopharma (QNTM) Total Liabilities (2018 - 2026)
Quantum Biopharma (QNTM) posted Total Liabilities of $16.3 million for Q1 2026, up 169.81% sequentially from $6.1 million in Q4 2025, and up 58.02% YoY from $10.3 million in Q1 2025.
Quantum Biopharma (QNTM) Total Liabilities (2018 - 2026) Analysis & Trends
Quantum Biopharma has reported Total Liabilities for 9 years, with the latest figure at $16.3 million in Q1 2026.
- Quarterly Total Liabilities rose 58.02% year-over-year to $16.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $16.3 million (up 58.02% YoY) and the FY2025 annual result came in at $6.1 million, down 9.29% from the prior year.
- Total Liabilities advanced to $16.3 million in Q1 2026 per QNTM's latest filing, from $6.1 million in the prior quarter.
- Over five years, Total Liabilities peaked at $16.3 million in Q1 2026 and troughed at $3.7 million in Q3 2024.
- A 5-year average of $7.7 million and a median of $6.6 million in 2025 frame the typical range for Total Liabilities.
- The sharpest annual moves came in 2023 and 2025: Total Liabilities slumped 41.98% in 2023, then jumped 163.62% in 2025.
- Over 5 years, Total Liabilities stood at $7.9 million in 2022, then sank by 41.98% to $4.6 million in 2023, then surged by 46.29% to $6.7 million in 2024, then dropped by 9.29% to $6.1 million in 2025, then surged by 169.81% to $16.3 million in 2026.
- According to Business Quant data, Total Liabilities over the past three periods registered $16.3 million, $6.1 million, and $6.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 7.18 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 10.02 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 1.62 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 4.20 Bn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 4.00 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 4.20 Bn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 3.22 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 1.35 Bn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 10.03 Bn |
| 10 | Quantum Biopharma | 15.44 Mn | 11.80 Mn | - | 8.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 8.30 Mn |
| Mar 31, 2026 | 16.35 Mn |
| Dec 31, 2025 | 6.06 Mn |
| Sep 30, 2025 | 6.65 Mn |
| Jun 30, 2025 | 13.25 Mn |
| Mar 31, 2025 | 10.34 Mn |
| Dec 31, 2024 | 6.68 Mn |
| Sep 30, 2024 | 3.68 Mn |
| Jun 30, 2024 | 5.04 Mn |
| Mar 31, 2024 | 3.92 Mn |
| Dec 31, 2023 | 4.57 Mn |
| Dec 31, 2022 | 7.87 Mn |
| Dec 31, 2021 | 8.83 Mn |
| Dec 31, 2020 | 5.66 Mn |
| Dec 31, 2019 | 6.99 Mn |
| Dec 31, 2018 | 1.32 Mn |